| Aug 10 |
Charles River Laboratories: Q2, Cost Structure Streamlining (Rating Upgrade)
|
| Aug 8 |
Baird cuts Charles River Labs to neutral, cites lagging recovery
|
| Aug 8 |
Big Pharma Cuts R&D, Sending Shudders Through Industry
|
| Aug 8 |
Q2 2024 Charles River Laboratories International Inc Earnings Call
|
| Aug 7 |
Wall Street Ends Wednesday In The Red As Risk Sentiment Remains Fragile: S&P 500 Movers At The Close
|
| Aug 7 |
S&P 500 Gains and Losses Today: Fortinet Stock Surges on Earnings Beat
|
| Aug 7 |
Charles River Laboratories International Inc (CRL) Q2 2024 Earnings Call Transcript
|
| Aug 7 |
Charles River (CRL) Q2 Earnings Beat Estimates, 2024 View Down
|
| Aug 7 |
Charles River Labs Says It Expects Sales To Fall, Sending Its Stock Tumbling
|
| Aug 7 |
Charles River Labs Plummets 14% On 'Bleaker' Expectations For 2024
|
